In the genetic disorder APL, PML is fused to the retinoic acid receptor alpha, resulting in the aberrant track-like structure of promyelocytic leukemia nuclear bodies, leading to the complete loss of PML-NB functionality (57, –, 59). This evidence concerns the gene RARA and acute promyelocytic leukemia.